AbbVie doubles down on Gedeon Richter pact that brought Vraylar to the world

They worked together before on bipolar medication Vraylar, and now Allergan—ahem, AbbVie—will try to repeat that success with Gedeon Richter.

AbbVie, which of course absorbed Allergan two years ago, announced it will double down on a partnership with the Hungarian pharmaceutical company to create dopamine receptor modulators for neuropsychiatric diseases.